Saltar al contenido
Merck

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

Bioorganic & medicinal chemistry letters (2010-04-07)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Philip J Skinner, Jae-Kyu Jung, Jerry Xu, Martin C Cherrier, Peter J Webb, Graeme Semple, Carleton R Sage, Jens Knudsen, Ruoping Chen, Andrew K Taggart, Ester Carballo-Jane, Jeremy G Richman
RESUMEN

Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Nicotinic acid, ≥99.5% (HPLC)
Sigma-Aldrich
Nicotinic acid, ≥98%
Supelco
Nicotinic acid, analytical standard
Sigma-Aldrich
Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Nicotinic acid, meets USP testing specifications